Hiroyoshi Mori

Showing 1-3 of 3 articles

Coronary interventions

Thromboresistance and functional healing in the COBRA PzF stent versus competitor DES: implications for dual antiplatelet therapy

Jinnouchi H, Mori H, Cheng Q, Kutyna M, Torii S, Sakamoto A, Guo L, Acampado E, Gupta A, Kolodgie F, Virmani R, Finn A

July 19, 2019 | 10.4244/EIJ-D-18-00740

Stents and scaffolds

Acute thrombogenicity of fluoropolymer-coated versus biodegradable and polymer-free stents

Torii S, Cheng Q, Mori H, Lipinski M, Acampado E, Perkins L, Hossainy S, Pacetti S, Kolodgie F, Virmani R, Finn A

March 20, 2019 | 10.4244/EIJ-D-17-00728

Coronary interventions

Pathological aspects of bioresorbable stent implantation

Sanchez O, Yahagi K, Byrne R, Mori H, Zarpak R, Wittchow E, Foin N, Virmani R, Joner M

May 19, 2015 | 10.4244/EIJV11SVA39

1

Latest news

Trends and predictors of radiation exposure in percutaneous coronary intervention: the PROTECTION VIII study

FREE ARTICLE - Thomas J. Stocker et al

January 24, 2022

Three-year TAVI outcomes for BAV vs TAV

FREE ARTICLE - Dao Zhou et al.

January 20, 2022

EuroCTO Club Consensus on Dual Lumen Microcatheters for CTO Recanalisation; Predicting Radial Crossover in ACS, the MATRIX score; DAPT duration for BRS; and more…

December 17, 2021

Percutaneous management of left ventricular assist device outflow graft obstruction

FREE ARTICLE - Aleksandra Gasecka et al.

January 19, 2022

Lipid-rich plaque density and LDL-C in statin-treated vs statin-naïve patients

FREE ARTICLE - Rebecca Torguson et al.

January 17, 2022

Redo transcatheter mitral valve replacement in mitral annular calcification

FREE ARTICLE - Jennifer Jdaidani et al

January 13, 2022

TAVI vs SAVR in bicuspid aortic valve stenosis

FREE ARTICLE - Monil Majmundar et al.

January 12, 2022

Valvular disease